These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 13697725)

  • 1. Paralysis agitans syndrome. A report on the results of testing and treatment with high frequency (sedac) currents.
    EYRES AE; KNIGHT J; REITER R
    J Mich State Med Soc; 1961 Jun; 60():775-82. PubMed ID: 13697725
    [No Abstract]   [Full Text] [Related]  

  • 2. Paralysis agitans syndrome: a report of the results of testing and treatment with high frequency (sedac) currents.
    EYRES AE
    Dis Nerv Syst; 1961 Apr; 22(4)Suppl():86-9. PubMed ID: 13697726
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients.
    Welter ML; Houeto JL; Bonnet AM; Bejjani PB; Mesnage V; Dormont D; Navarro S; Cornu P; Agid Y; Pidoux B
    Arch Neurol; 2004 Jan; 61(1):89-96. PubMed ID: 14732625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts in therapy. Treatment of Parkinson's disease. 1. Medicinal therapy. 2.
    DOSHAY LJ
    N Engl J Med; 1961 May; 264():1097-9. PubMed ID: 13723989
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Parkinson's disease. 1. Medicinal therapy. 1.
    DOSHAY LJ
    N Engl J Med; 1961 May; 264():988-90. PubMed ID: 13723993
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Parkinson disease].
    PORTELLA A
    Rass Int Clin Ter; 1954 Apr; 34(8):253-5. PubMed ID: 13177940
    [No Abstract]   [Full Text] [Related]  

  • 7. Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease.
    Payoux P; Remy P; Damier P; Miloudi M; Loubinoux I; Pidoux B; Gaura V; Rascol O; Samson Y; Agid Y
    Arch Neurol; 2004 Aug; 61(8):1307-13. PubMed ID: 15313852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGENTS for treatment of Parkinson's disease.
    N Engl J Med; 1957 Apr; 256(15):699-701. PubMed ID: 13451922
    [No Abstract]   [Full Text] [Related]  

  • 9. Paralysis agitans.
    MAUDSLEY HF
    Med J Aust; 1953 Nov; 2(19):730-2. PubMed ID: 13119012
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of parkinsonism].
    DOSHAY LJ
    Resen Clin Cient; 1957 Feb; 26(2):43-6. PubMed ID: 13453814
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe restless legs syndrome following bilateral subthalamic stimulation to treat a patient with Parkinson's disease].
    Parra J; Brocalero-Camacho A; Sancho J; Gallego-Sánchez JM; Ortiz-Sánchez P; Barcia-Albacar JA
    Rev Neurol; 2006 Jun 16-30; 42(12):766-7. PubMed ID: 16775805
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of Parkinson's disease with electric stimulation].
    Heikkinen E; Erola T; Tuominen J; Juolasmaa A; Haapaniemi T; Myllylä V
    Duodecim; 2004; 120(7):789-96. PubMed ID: 15154298
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations on the effect of electroshock treatment on patients with parkinsonism.
    FROMM GH
    Bull Tulane Univ Med Fac; 1959 Feb; 18(2):71-3. PubMed ID: 13629283
    [No Abstract]   [Full Text] [Related]  

  • 14. [When drugs are not enough: electrical impulses in Parkinson disease, epilepsy and pain].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Nov; 145(48):14. PubMed ID: 14724991
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional balance performance in patients with Parkinson's disease after long-term treatment with subthalamic nucleus high-frequency stimulation.
    Nilsson MH; Jarnlo GB; Rehncrona S
    Parkinsonism Relat Disord; 2008; 14(4):291-7. PubMed ID: 18024162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic electrical stimulation of the globus pallidus for treatment of Parkinson's disease].
    Ogura M; Tanaka S; Nishibayashi H; Itakura T
    No Shinkei Geka; 2004 Jul; 32(7):763-72. PubMed ID: 15462368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Parkinson disease therapy: how great is the progress? Possibilities, limitations and future prospects?].
    Schulz-Hanke I
    Dtsch Med Wochenschr; 2003 Dec; 128(51-52):2689-90. PubMed ID: 14725284
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute hallucinosis secondary to pagitane hydrochloride administration.
    PIERIK MG
    N Engl J Med; 1954 Dec; 251(26):1058. PubMed ID: 13214391
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Parkinsonism].
    MACIAS CASTRO I
    Arch Hosp Univ; 1954; 6(5):511-4. PubMed ID: 14362924
    [No Abstract]   [Full Text] [Related]  

  • 20. The antiparkinson activity of benactyzine.
    HIMWICH HE; RINALDI F
    Arch Int Pharmacodyn Ther; 1957 Mar; 110(1):119-27. PubMed ID: 13425754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.